Best Diagnostic & Research Stocks to Buy Now (2024)Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.
Industry: Diagnostics & Research
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| ICLR | ICON PLC | Ireland | $24.81B | 82,683,805 | 95.42% | 0.00% | ||
| FONR | FONAR CORP | United States | $113.14M | 6,710,807 | 47.70% | 3.51% | ||
| STRR | STAR EQUITY HOLDINGS INC | United States | $13.91M | 15,848,202 | 3.66% | 96.34% | Net Buying | Net Selling |
| RVTY | REVVITY INC | United States | $12.61B | 123,529,821 | 86.51% | 2.53% | Net Buying | Net Buying |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | United States | $11.70B | 51,349,770 | 96.79% | 3.21% | Net Selling | Net Selling |
| A | AGILENT TECHNOLOGIES INC | United States | $39.96B | 293,055,284 | 87.43% | 1.18% | Net Buying | Net Selling |
| NEOG | NEOGEN CORP | United States | $2.59B | 216,607,746 | 98.56% | 1.44% | Net Buying | Net Buying |
| QGEN | QIAGEN NV | Netherlands | $9.37B | 228,202,755 | 61.40% | 0.00% | ||
| IDXX | IDEXX LABORATORIES INC | United States | $40.65B | 83,089,381 | 87.71% | 1.68% | Net Selling | Net Selling |
| TMO | THERMO FISHER SCIENTIFIC INC | United States | $218.01B | 381,312,268 | 89.26% | 0.87% | Net Selling | Net Selling |
| ENZ | ENZO BIOCHEM INC | United States | $54.81M | 51,225,734 | 31.93% | 48.12% | Net Selling | |
| LH | LABORATORY CORP OF AMERICA HOLDINGS | United States | $16.68B | 84,100,000 | 95.77% | 1.52% | Net Selling | Net Selling |
| MEDP | MEDPACE HOLDINGS INC | United States | $12.08B | 30,983,399 | 27.34% | 72.66% | Net Selling | Net Selling |
| DGX | QUEST DIAGNOSTICS INC | United States | $15.04B | 111,091,574 | 87.75% | 1.76% | Net Selling | Net Selling |
| CSTL | CASTLE BIOSCIENCES INC | United States | $535.55M | 27,449,983 | 84.19% | 15.81% | Net Selling | Net Selling |
| SHC | SOTERA HEALTH CO | United States | $3.20B | 282,832,200 | 61.96% | 38.04% | Net Selling | Net Selling |
| DHR | DANAHER CORP | United States | $182.06B | 740,686,541 | 75.94% | 24.06% | Net Selling | Net Selling |
| TWST | TWIST BIOSCIENCE CORP | United States | $1.80B | 57,818,022 | 88.25% | 11.75% | Net Selling | Net Selling |
| WAT | WATERS CORP | United States | $18.26B | 59,202,626 | 92.46% | 7.54% | Net Selling | Net Selling |
| MTD | METTLER TOLEDO INTERNATIONAL INC | United States | $26.48B | 21,478,705 | 94.58% | 4.52% | Net Selling | Net Buying |
| SERA | SERA PROGNOSTICS INC | United States | $335.28M | 32,425,661 | 34.04% | 21.12% | Net Selling | Net Selling |
| IQV | IQVIA HOLDINGS INC | United States | $42.47B | 181,500,000 | 53.95% | 46.05% | Net Selling | Net Selling |
| EXAS | EXACT SCIENCES CORP | United States | $10.67B | 181,530,967 | 88.62% | 3.40% | Net Selling | Net Selling |
| XGN | EXAGEN INC | United States | $24.30M | 17,235,751 | 36.96% | 63.04% | Net Selling | Net Selling |
| PSNL | PERSONALIS INC | United States | $63.13M | 50,503,889 | 43.52% | 18.39% | Net Selling | Net Buying |
| PRPO | PRECIPIO INC | United States | $8.83M | 1,430,292 | 0.61% | 99.39% | Net Buying | Net Buying |
| NTRA | NATERA INC | United States | $11.02B | 120,757,877 | 78.43% | 21.57% | Net Selling | Net Selling |
| OLK | OLINK HOLDING AB (PUBL) | Sweden | $2.87B | 124,342,715 | 30.18% | 0.00% | ||
| FLGT | FULGENT GENETICS INC | United States | $596.59M | 29,784,771 | 48.02% | 42.49% | Net Selling | Net Selling |
| DRIO | DARIOHEALTH CORP | Israel | $43.28M | 29,442,532 | 29.42% | 53.98% | ||
| ACRS | ACLARIS THERAPEUTICS INC | United States | $84.40M | 70,925,042 | 56.85% | 43.15% | Net Selling | Net Selling |
| GH | GUARDANT HEALTH INC | United States | $2.09B | 121,712,724 | 64.42% | 35.58% | Net Selling | Net Selling |
| STIM | NEURONETICS INC | United States | $104.74M | 29,756,053 | 50.13% | 49.87% | Net Selling | Net Selling |
| NEO | NEOGENOMICS INC | United States | $1.77B | 127,610,039 | 72.39% | 27.61% | Net Selling | Net Selling |
| DMTK | DERMTECH INC | United States | $20.25M | 34,623,443 | 15.75% | 77.74% | Net Selling | Net Selling |
| BNR | BURNING ROCK BIOTECH LTD | China | $87.04M | 102,396,208 | 19.66% | 0.00% | ||
| OCX | ONCOCYTE CORP | United States | $20.19M | 8,273,073 | 5.82% | 94.18% | Net Buying | Net Buying |
| RDNT | RADNET INC | United States | $3.35B | 68,475,443 | 64.36% | 35.64% | Net Selling | |
| BGLC | BIONEXUS GENE LAB CORP | Malaysia | $10.48M | 17,667,663 | 0.59% | 97.91% | ||
| LAB | STANDARD BIOTOOLS INC | United States | $684.68M | 290,117,930 | 16.74% | 33.34% | Net Buying | Net Buying |
| PRE | PRENETICS GLOBAL LTD | Hong Kong | $60.21M | 12,114,922 | 10.11% | 0.00% | ||
| APDN | APPLIED DNA SCIENCES INC | United States | $4.24M | 848,935 | 11.48% | 88.52% | ||
| XWEL | XWELL INC | United States | $7.53M | 4,183,435 | 1.65% | 98.35% | Net Buying | |
| BDSX | BIODESIX INC | United States | $122.15M | 96,942,061 | 17.45% | 72.27% | Net Buying | Net Selling |
| CDNA | CAREDX INC | United States | $391.45M | 51,778,523 | 78.90% | 21.10% | Net Selling | Net Selling |
| MDXH | MDXHEALTH SA | Belgium | $6.68M | 27,038,094 | 11.79% | 88.21% | ||
| CHEK | CHECK-CAP LTD | Israel | $13.28M | 5,849,756 | 1.07% | 0.00% | ||
| ME | 23ANDME HOLDING CO | United States | $221.66M | 482,916,636 | 27.87% | 2.59% | Net Buying | Net Selling |
| NDRA | ENDRA LIFE SCIENCES INC | United States | $2.67M | 11,035,659 | 1.19% | 8.73% | Net Buying | |
| ULS | UL SOLUTIONS INC | United States | N/A | 200,000,000 | 0.00% | 0.30% | Net Selling | Net Selling |
| PRPH | PROPHASE LABS INC | United States | $89.32M | 18,045,209 | 9.36% | 57.17% | ||
| AWH | ASPIRA WOMEN's HEALTH INC | United States | $40.49M | 12,344,104 | 0.84% | 99.16% | Net Buying | |
| OPK | OPKO HEALTH INC | United States | $850.33M | 696,991,667 | 17.43% | 82.57% | Net Buying | Net Buying |
| NOTV | INOTIV INC | United States | $110.64M | 25,790,680 | 18.17% | 43.71% | Net Buying | |
| VNRX | VOLITIONRX LTD | United States | $73.04M | 82,068,442 | 7.76% | 40.12% | Net Buying | |
| ISPC | ISPECIMEN INC | United States | $2.54M | 9,087,467 | 4.31% | 71.05% | Net Buying | |
| GENE | GENETIC TECHNOLOGIES LTD | Australia | $503.22k | 115,417,246 | 0.02% | 0.00% | ||
| MYGN | MYRIAD GENETICS INC | United States | $1.62B | 89,874,886 | 92.31% | 7.69% | Net Selling | Net Selling |
| BIAF | BIOAFFINITY TECHNOLOGIES INC | United States | $27.75M | 11,514,354 | 1.36% | 37.32% | Net Buying | Net Buying |
| PMD | PSYCHEMEDICS CORP | United States | $14.59M | 5,742,761 | 22.46% | 50.15% | Net Selling | |
| ILMN | ILLUMINA INC | United States | $19.23B | 158,900,000 | 89.29% | 1.98% | Net Selling | Net Buying |
| MYNZ | MAINZ BIOMED NV | Germany | $18.14M | 21,165,482 | 1.10% | 0.00% | ||
| TRIB | TRINITY BIOTECH PLC | Ireland | $14.03M | 153,310,280 | 3.93% | 0.00% | ||
| MMA | ALTA GLOBAL GROUP LTD | Australia | N/A | 10,223,079 | 0.00% | 0.00% | ||
| CNTG | CENTOGENE NV | Germany | $13.25M | 27,595,835 | 9.75% | 0.00% | ||
| TTOO | T2 BIOSYSTEMS INC | United States | $15.10M | 5,512,332 | 0.51% | 99.49% | Net Selling |
Diagnostic & Research Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.